NCNO vs DBD
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Aug 22, 2026
NCNO
DBD
Investment Advisor Scores
DBD
AI Analyst Insights
Detailed Metrics Comparison
| Metric | NCNO | DBD | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 14.5985 | 12.1655 | DBD |
| PEG Ratio | 0 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 10.6% | 1.7% | NCNO |
| Earnings Growth | 147.6% | 34.2% | NCNO |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 37.9/100 | 59.7/100 | DBD |
| Profit Margin | 2.2% | 2.9% | DBD |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | SELL | HOLD | DBD |
Relative Price Performance (Last 90 Days)
Current Technical Phase
NCNO
MarkupPrice above SMA50, rising 50-day trend (10.2% over 20 days), RSI 67
DBD
MarkdownPrice below a falling SMA50 (slope -2.1%), weak momentum, RSI 38
Fundamentals Snapshot
| Metric | NCNO | DBD |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 20.1 | 10.0 |
| Trailing P/E | 169.7 | 22.3 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.1% | 0.0% |
| Gross Margin | 0.6% | 0.3% |
| Operating Margin | 0.1% | 0.1% |
| EPS | 0.12 | 3.04 |
| Dividend Yield | — | — |